Procainamide hydrochloride
CAS: 614-39-1
Ref. 3D-FA35455
2g | 136,00 € | ||
5g | 200,00 € | ||
10g | 320,00 € | ||
25g | 522,00 € | ||
50g | 796,00 € |
Información del producto
- 4-Amino-N-(2-diethylaminoethyl)benzamide hydrochloride
- 4-Amino-N-(2-Diethylaminoethyl)Benzamide Hydrochloride
- 4-Amino-N-[2-(diethylamino)ethyl]benzamide monohydrochloride
- 4-amino-N-[2-(diethylamino)ethyl]benzamide hydrochloride (1:1)
- Amidoprocaine
- Amisalin
- Benzamide, 4-amino-N-[2-(diethylamino)ethyl]-, hydrochloride (1:1)
- Benzamide, 4-amino-N-[2-(diethylamino)ethyl]-, monohydrochloride
- Benzamide, p-amino-N-[2-(diethylamino)ethyl]-, monohydrochloride
- Cardiorytmin
- Ver más sinónimos
- Hc 5006
- Novocaine amide hydrochloride
- Novocamid hydrochloride
- Procainamide monohydrochloride
- Procainamidi Hydrochloridum
- Procamid
- Procamide
- Procan SR
- Procapan
- Procardyl
- Pronestyl
- Pronestyl hydrochloride
- Spicain amide
- procainamide HCl
4-Amino-N-(2-diethylaminoethyl)benzamide hydrochloride (DEAB) is a drug that belongs to the group of pharmacological agents. It has been used as a vasodilator and as an antiarrhythmic agent for ventricular arrhythmias. DEAB blocks the action of DNA methyltransferase, which is involved in the regulation of gene transcription and replication. The drug also increases the activity of procaine by blocking its deactivation by ryanodine receptors, which are located on cells in cardiac muscle. This leads to increased contractility and improved cardiac function. DEAB has been shown to be effective in treating structural heart disease such as chronic myocardial infarction and cardiomyopathy when combined with procainamide.
Propiedades químicas
Consulta técnica sobre: 3D-FA35455 Procainamide hydrochloride
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.